Samil Pharm (000520)

Seoul
9,550.00
0.00(0.00%)
  • Volume:
    3,902
  • Bid/Ask:
    9,540.00/9,550.00
  • Day's Range:
    9,500.00 - 9,600.00

000520 Overview

Prev. Close
9,550
Day's Range
9,500 - 9,600
Revenue
123B
Open
9,500
52 wk Range
8,975 - 24,400
EPS
110.79
Volume
3,902
Market Cap
128.07B
Dividend (Yield)
75.00 (0.79%)
Average Vol. (3m)
121,974
P/E Ratio
86.20
Beta
0.7
1-Year Change
-1.76%
Shares Outstanding
12,536,320
Next Earnings Date
Aug 06, 2021
What is your sentiment on Samil Pharm?
or
Vote to see community's results!

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyNeutralSellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyBuyStrong SellStrong Sell

Samil Pharm Company Profile

Samil Pharm Company Profile

Industry
Major Drugs
Employees
395

SAMIL PHARMACEUTICAL CO., LTD is a Korea-based company mainly engaged in the manufacture of medicines. The Company’s products portfolio consists of gastro-intestinal drugs such as antiulcerants, gastroprokinetic agents, digestive enzymes with nutrients and laxatives under the brand names of Plybutine, Gliptide and others; antipyretic, analgesic and anti-inflammatory agents under the brand name Brufen; nutritional supplements such as vitamins, minerals and immunosuppressants, and others including antigout agents, anti-parkinsonism agents and others. In addition, it is engaged in the provision of miscellaneous goods. The Company distributes its products within domestic market and to overseas markets. On November 29, 2013, it transferred its entire shares of a Korea-based company, which is engaged in the sale of medical products.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.